Drug treatment and adherence of subjects <40 years with diagnosis of heterozygous familial hypercholesterolemia

This analysis of young adult HeFH patients showed that therapy change was quite frequent, and probably reflected adjustments according to individual response. Adherence and persistence were inadequate, even in this population at high cardiovascular risk, and they need to be improved through proper patient education and shared treatment decision-making approach.